List of works by Florian Krammer

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans

scientific article

20th International Conference on Emerging Infectious Diseases in the Pacific Rim Organized by the United States-Japan Cooperative Medical Sciences Program (USJCMSP)

scientific article published on 02 April 2019

A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice

scientific article published on 22 July 2022

A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)

scientific article published on 29 August 2020

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2

scientific article published on 17 April 2020

A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study

scholarly article by Raffael Nachbagauer et al published 25 July 2018 in Vaccines

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

scientific article published on 19 April 2020

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

scientific article published on 17 December 2020

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

scientific article published on 31 July 2020

A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model

scientific article published on 23 November 2021

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

scientific article published on 26 June 2020

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

scientific article published on 30 July 2020

A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies

article

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates

scientific article

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice

scientific article published on 22 September 2016

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

scientific article published on 07 December 2020

A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.

scientific article published on 17 June 2017

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains

scientific article published on 19 July 2019

A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses

scientific article (publication date: 9 March 2017)

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

scientific article

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 18 March 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 12 May 2020

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

scientific article published on 14 September 2017

A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.

scientific article

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

scientific article published on 17 January 2020

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

scientific article published on 13 July 2020

Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies

scientific article

Advances in the development of influenza virus vaccines.

scientific article

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

scientific article

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans

scientific article

Alternative influenza vaccines made by insect cells

scientific article published on July 2010

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

scientific article published on 10 October 2017

An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses

scientific article published on 01 June 2020

An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses

scientific article

An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.

scientific article published on 17 January 2015

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans

scientific article

An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model

scientific article published on 20 May 2019

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

scientific article published on 01 September 2020

An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains

scientific article published on 18 September 2019

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

scientific article published on 4 April 2018

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.

scientific article

Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response

scientific article published on 16 December 2019

Animal models for influenza viruses: implications for universal vaccine development

scientific article

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

scientific article

Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks

scientific article published on 14 August 2020

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus

article

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.

scientific article

Antibody responses to influenza A(H1N1)pdm infection

scientific article published on 07 May 2020

Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans

article

Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance

Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses

article

Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients

scientific article published on 30 October 2020

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

scientific article

Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit

scientific article published on 14 May 2020

Attenuated influenza virus construct with enhanced hemagglutinin protein expression

scientific article

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination

scientific article

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

scientific article published on June 2016

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

scientific article published on 03 April 2019

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.

scientific article published on 11 April 2018

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

scientific article published on 05 March 2019

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

scholarly article by Raffael Nachbagauer published in August 2018

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

scientific article published on 23 December 2021

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.

scientific article published on 22 March 2018

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

scientific article published on 01 October 2019

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

scientific article

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

scientific article

COVID-19: Staging of a New Disease

scientific article published on 10 October 2020

Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States

scientific article

Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin

scientific article

Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity

scientific article published on 09 September 2020

Characterization of swine-origin H1N1 canine influenza viruses

scientific article published on 01 January 2019

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

scientific article published on 29 March 2017

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

article

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

scientific article published on 10 April 2013

Comparative Immunogenicity of the 2014-2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children

scientific article published on 12 August 2019

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 06 July 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 17 October 2020

Convalescent plasma treatment of severe COVID-19: A matched control study

scientific article published on 23 May 2020

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

scientific article published on 15 September 2020

Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice

scientific article published on 15 September 2020

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin

scientific article published on 21 October 2019

Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats

scientific article

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

scientific article

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

scientific article published on 20 June 2018

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.

scientific article published on 22 March 2016

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

scientific article

Defining the risk of SARS-CoV-2 variants on immune protection

scientific article published on 31 March 2022

Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy

scientific article published on 30 January 2019

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

scientific article published on 15 September 2020

Dengue and Zika: The Complexities of Being Related

scientific article published on 06 May 2019

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

scientific article published on 09 November 2020

Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach

scientific article published on 29 May 2019

Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards

scientific article published on 6 December 2017

Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers

scholarly article by Dibyendu Kumar Das et al published 9 August 2018 in Cell

Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination

scientific article published on 28 July 2016

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

scientific article published on 25 September 2020

Distinct systems serology features in children, elderly and COVID patients

scientific article published on 18 May 2020

Divergent H7 immunogens offer protection from H7N9 virus challenge.

scientific article

Domestic pigs are susceptible to infection with influenza B viruses

scientific article

Editorial overview: Tough targets

scientific article published on 01 August 2018

Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance

scientific article

Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination

scientific article published on 01 December 2019

Emerging influenza viruses and the prospect of a universal influenza virus vaccine.

scientific article

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

scientific article (publication date: 30 March 2017)

Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals

scientific article published on 03 June 2020

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

scientific article published on 03 October 2016

Erratum: Advances in the development of influenza virus vaccines

article

Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64

article

Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells

scientific article

Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

scientific article published on 08 May 2020

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system

scientific article

Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase

scientific article published on 28 August 2019

Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice

scientific article published on 05 December 2020

Fighting influenza through hemagglutinin diversity

scientific article published on 01 March 2019

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

scientific article published on 31 August 2017

Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination

scientific article published on 02 September 2019

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

scientific article published on 29 August 2017

Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.

scientific article published on 14 September 2017

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

scientific article

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge

scientific article

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

scientific article published on 13 February 2013

H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.

scientific article published in March 2018

H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids

scientific article published on 15 August 2013

Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus

scientific article published on July 2015

Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets

scientific article published on 30 December 2015

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

scientific article

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice

scientific article

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

scientific article

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

scientific article published on 31 July 2013

Hemagglutinin-stalk antibody responses following trivalent inactivated influenza vaccine immunization of pregnant women and association with protection from influenza virus illness

scientific article published on 27 September 2019

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.

scientific article

Heterologous viral protein interactions within licensed seasonal influenza virus vaccines

scientific article published on 10 January 2020

High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination

scientific article published on 7 May 2015

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine

scientific article

High-complexity extracellular barcoding using a viral hemagglutinin

scientific article published on 27 January 2020

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective

scientific article published on 22 September 2020

Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model

scientific article published in Nature Communications

Human germinal centres engage memory and naive B cells after influenza vaccination

scientific article published on 31 August 2020

Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region

scientific article published on 05 May 2020

Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study

scientific article published on 25 September 2020

Immune history profoundly affects broadly protective B cell responses to influenza.

scientific article

Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice

scholarly article by Felix Broecker published in October 2018

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

scientific article published on 17 October 2019

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

scientific article published on 06 January 2021

Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.

scientific article published on 13 March 2018

In Utero Vertical Transmission of Coronavirus Disease 2019 in a Severely Ill 29-week Preterm Infant

scientific article published on 01 July 2020

In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen

scientific article

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

scientific article published on 24 September 2020

Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans

scientific article published on February 2017

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

scientific article

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

scientific article

Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin

scientific article published on 22 May 2013

Influenza

Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins

scientific article published on 13 January 2016

Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination

scientific article published on 9 September 2017

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.

scientific article published on January 2013

Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation

scientific article published on 25 January 2018

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.

scientific article published in April 2018

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

scientific article published on 19 September 2017

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

scientific article published on 21 January 2020

Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals

scientific article published on 19 February 2019

Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication.

scientific article published on 27 September 2017

Influenza virus hemagglutinin stalk-based antibodies and vaccines

scientific article

Influenza virus infection in guinea pigs raised as livestock, Ecuador

scientific article

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis

scientific article

Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection

scientific article published on 30 November 2016

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

scientific article

Insect cells for antibody production: evaluation of an efficient alternative.

scientific article

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

scientific article published on 18 August 2021

Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA

scientific article published on 10 December 2021

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

scientific article published on 17 September 2020

Introductions and early spread of SARS-CoV-2 in the New York City area

scientific article published on 11 April 2020

Introductions and early spread of SARS-CoV-2 in the New York City area

scientific article published on 29 May 2020

Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells

scientific article published on 16 November 2015

Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Toward a Universal Influenza Virus Vaccine: Potential Target Antigens and Critical Aspects for Vaccine Development

scientific article published on 29 June 2017

MHC class II proteins mediate cross-species entry of bat influenza viruses

scientific article published in Nature

Mapping SARS-CoV-2 antigenic relationships and serological responses

scientific article published on 11 October 2023

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

preprint published on 06 July 2020

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

scientific article published on 14 September 2020

Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines

scientific article published on 13 December 2019

Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave

scientific article published on 08 June 2021

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

scientific article

Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein

scientific article published on 14 February 2020

Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study

scientific article published on 15 October 2019

Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus

scientific article published on 06 July 2020

Moving from Empirical to Rational Vaccine Design in the 'Omics' Era

scientific article published on 14 August 2019

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs

article

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

scientific article published on 3 April 2018

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge

scientific article

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

scientific article published on 26 October 2020

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

scientific article published on 24 March 2020

Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

scientific article

New England harbor seal H3N8 influenza virus retains avian-like receptor specificity

scientific article published on 18 February 2016

Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses

scientific article published on 29 April 2015

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

scientific article published on 21 November 2020

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

scientific article published on 26 July 2020

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination

scientific article published on 20 June 2019

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses

scientific article published on 09 June 2020

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

scientific article published on 07 June 2017

Novel correlates of protection against pandemic H1N1 influenza A virus infection

scientific article published on 03 June 2019

Novel universal influenza virus vaccine approaches

scientific article

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

scientific article published in Nature Communications

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

scientific article

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.

scientific article

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.

scientific article

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

scientific article published on 19 September 2016

Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?

scientific article published in 2020

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

scientific article published on 06 December 2019

Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses

scientific article published on 17 October 2020

Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

scientific article published on 03 November 2020

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults

scientific article published on 12 July 2019

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.

scientific article

Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans

scientific article published on 01 December 2020

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity

scientific article published in December 2017

Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections

scientific article published on 8 February 2017

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine

scientific article published on 01 April 2019

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies

scientific article published in 2018

Purification of infective baculoviruses by monoliths

scientific article published on 25 March 2013

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

scientific article published on 15 August 2020

Real Time Investigation of a large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

scientific article published on 15 May 2020

Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

scientific article published on 30 November 2020

Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs

scientific article published on 22 May 2013

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

scientific article published on 03 November 2020

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity

scientific article

Robust and specific secretory IgA against SARS-CoV-2 detected in human milk

scientific article published on 26 October 2020

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

scientific article published on 28 October 2020

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

scientific article published on 02 November 2020

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

scientific article published on 01 June 2020

SARS-CoV-2 Vaccines: Status Report

scientific article published on 03 April 2020

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

scientific article published on 13 September 2020

SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation

scientific article published on 21 November 2020

SARS-CoV-2 vaccines in development

scientific article published on 23 September 2020

SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19

scientific article published on 05 September 2020

SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study

scientific article published on 28 November 2020

Scientific consensus on the COVID-19 pandemic: we need to act now

scientific article published on 15 October 2020

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

scientific article published on 10 April 2019

Seroconversion in household members of COVID-19 outpatients

scientific article published on 15 June 2020

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

scientific article published on 01 September 2020

Serology assays to manage COVID-19

scientific article

Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak

scientific article published on 28 May 2020

Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.

scientific article published on 26 February 2018

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

scientific article published on 23 October 2020

Stopping emerging influenza viruses at their origin

scientific article published on 19 May 2017

Strategies to induce broadly protective antibody responses to viral glycoproteins

scientific article published on 23 February 2017

Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses

scientific article published on 23 July 2020

Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.

scientific article

Symptomatic SARS-CoV-2 infections display specific IgG Fc structures

scientific article published on 18 May 2020

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice

scientific article

Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses

scientific article

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

scientific article published on 22 June 2020

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

scientific article published on 20 May 2020

The Quest for a Universal Flu Vaccine: Headless HA 2.0.

scientific article published on October 2015

The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines

scientific article published on 25 October 2013

The human antibody response to influenza A virus infection and vaccination

scientific article published on 01 June 2019

The influenza virus hemagglutinin head evolves faster than the stalk domain

scientific article published in Scientific Reports

The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain

scientific article published on 12 August 2019

Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model

scientific article published in January 2018

To our readers: Important notice

scientific article published on 09 July 2020

Transfusion Reactions Associated with COVID-19 Convalescent Plasma Therapy for SARS-CoV-2

scientific article published on 30 October 2020

Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

scientific article

Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain

scientific article published on 01 April 2019

Universal influenza virus vaccines and therapeutic antibodies

scientific article

Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?

scholarly article by Jessica Tan et al published August 2018 in Current Opinion in Immunology

Universal influenza virus vaccines: need for clinical trials

scientific article published on January 2014

Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?

scientific article published on 20 November 2017

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge

scientific article published on 21 August 2019

Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.

scientific article

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

scientific article published in November 2017

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

scientific article published on 10 March 2015

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

scientific article published on 28 May 2015

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice

scientific article published on 06 August 2019

Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses

scientific article published on 01 December 2019

Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement

scientific article published on 16 April 2020

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

scientific article published on 18 May 2022